Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Arturo Molina
Based on 37 articles published since 2010
(Why 37 articles?)
||||
Expertise Level
The expertise of Arturo Molina ranks in the
  • Top 0.19%
  • ... of 145,674 published authors worldwide on Prostatic Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 37 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Miscellaneous institutions in Menlo Park      
2019
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. Electronic address: · Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Janssen Research & Development, Spring House, PA, USA. · Department of Biostatistics, West Virginia University School of Public Health, Morgantown, WV, USA. · LabConnect LLC, Seattle, WA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Clinical Research & Development, Janssen Research & Development, Los Angeles, CA, USA. · Department of Biostatistics & Programming, Janssen Research & Development, San Diego, CA, USA. · Oncology Science Innovation, Janssen Research & Development, Menlo Park, CA, USA. · Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 31176622
2017
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
2016
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; CNIO-IBIMA Genitourinary Cancer Unit, Department of Medical Oncology, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain. · Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Medical Affairs, Janssen Diagnostics, Beerse, Belgium. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, La Jolla, CA, USA. · MIRA Research Institute for Biomedical Technology and Technical Medicine, University of Twente, Twente, The Netherlands. · Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. Electronic address: · Pubmed 27289566
  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Memorial Sloan Kettering Cancer Center, New York, NY. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, San Diego, CA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 26598756
2015
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
2014
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Department of Medicine, PK/PD Core Resource, Roswell Park Cancer Institute, Buffalo, New York. · Department of Urology, Roswell Park Cancer Institute, Buffalo, New York. · Section of Hematology and Oncology, University of Chicago, Chicago, Illinois. · Janssen Research and Development, Menlo Park, California. · Pubmed 25336698
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Hospital Universitario 12 de Octubre, Madrid, Spain. · Rigshospitalet, Copenhagen, Denmark. · National Institute of Oncology, Budapest, Hungary. · McMaster University, Hamilton, ON, Canada. · ICON Cancer Care, Brisbane, QLD, Australia. · University of Montreal, Montreal, QC, Canada. · Center for Oncology, Hospital Sírio-Libanês, São Paulo, Brazil. · OncoCare Cancer Centre, Singapore. · Centro Oncologico Belenus, Cuernavaca, Mexico. · University of Pisa, Pisa, Italy. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Duke Cancer Institute, Durham, NC, USA. · Pubmed 25242048
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, Los Angeles, CA. · Pubmed 24787968
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
Probable:    Miscellaneous institutions in Los Angeles      
2018
  • Glenn Heller, Martin Fleisher, and Howard I. Scher, Memorial Sloan Kettering Cancer Center · Howard I. Scher, Weill Cornell Medical College, New York, NY · Robert McCormack, Janssen Research & Development, Raritan, NJ · Thian Kheoh and Arturo Molina, Janssen Research & Development, Los Angeles · Dana T. Aftab, Exelixis, South San Francisco · Mohammad Hirmand, Medivation, San Francisco, CA · Matthew R. Smith, Massachusetts General Hospital, Boston · Ana Limon, Takeda Oncology, Cambridge, MA · Robert Dreicer, University of Virginia Medical School, Charlottesville, VA · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Ronald de Wit, Erasmus Medical Center, Rotterdam, the Netherlands · Karim Fizazi, Institut Gustave Roussy, Villejuif, and University of Paris Sud, Orsay, France · and Johann S. de Bono, The Institute of Cancer Research, and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 29272162
  • Glenn Heller, Memorial Sloan Kettering Cancer Center, New York, NY · Robert McCormack and Thian Kheoh, Janssen Research & Development, Raritan, NJ · Arturo Molina, Janssen Research & Development, Los Angeles, CA · Matthew R. Smith, Massachusetts General Hospital, Boston, MA · Robert Dreicer, University of Virginia Medical School, Charlottesville, VA · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Ronald de Wit, Erasmus Medical Center, Rotterdam, Netherlands · Dana T. Aftab, Exelixis, South San Francisco, CA · Mohammed Hirmand, Medivation, San Francisco, CA · Ana Limon-Carrera, Takeda Oncology, Cambridge, MA · Karim Fizazi, Institut Gustave Roussy, Villejuif, and University of Paris Sud, Orsay, France · Martin Fleisher, Memorial Sloan Kettering Cancer Center, New York, NY · Johann S. de Bono, The Institute of Cancer Research, and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom · and Howard I. Scher, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY. · Pubmed 29894273
2015
  • Department of Genitourinary Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Electronic address: · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Urology, University Hospitals of KU Leuven, Leuven, Belgium. · Department of Biostatistics Oncology, Janssen Research & Development, Raritan, New Jersey. · Department of Biostatistics and Programming, Janssen Research & Development, San Diego, California. · Department of WC Clinical Oncology, Janssen Research & Development, Los Angeles, California. · Department of Oncology, Janssen Research & Development, Los Angeles, California. · Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California. · Pubmed 26151676
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles · Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA · Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom · Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia · Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Celestia S. Higano, University of Washington, Seattle, WA · Jinhui Li, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School · Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center · Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA · Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington · Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System · Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA · Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX · Martin G. Sanda, Emory University School of Medicine, Atlanta, GA · Massimo Loda, King's College London, London, United Kingdom · Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA · and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
Probable:    UCLA   Contact    
2011
  • OrthoBiotech Oncology Research and Development, A Unit of Cougar Biotechnology and Institute of Urologic Oncology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California 90024, USA. · Pubmed 21239012
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 37 total) written by Arturo Molina about Prostatic Neoplasms:

  • Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone. 2019
  • Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials. 2018
  • Reply to C. Ren et al. 2018
  • The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population. 2017
  • Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies. 2016
  • Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer. 2016
  • Reply to A. Addeo and A. Bahl. 2016
  • Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer. 2015
  • Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer. 2015
  • Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results. 2015
Show List of Full Article Records
Google Searches

Learn more about Arturo Molina using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Menlo Park
Miscellaneous institutions in Los Angeles
UCLA
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Menlo Park
2019
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. Electronic address: · Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Janssen Research & Development, Spring House, PA, USA. · Department of Biostatistics, West Virginia University School of Public Health, Morgantown, WV, USA. · LabConnect LLC, Seattle, WA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Clinical Research & Development, Janssen Research & Development, Los Angeles, CA, USA. · Department of Biostatistics & Programming, Janssen Research & Development, San Diego, CA, USA. · Oncology Science Innovation, Janssen Research & Development, Menlo Park, CA, USA. · Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 31176622
2017
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
2016
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; CNIO-IBIMA Genitourinary Cancer Unit, Department of Medical Oncology, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain. · Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Medical Affairs, Janssen Diagnostics, Beerse, Belgium. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, La Jolla, CA, USA. · MIRA Research Institute for Biomedical Technology and Technical Medicine, University of Twente, Twente, The Netherlands. · Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. Electronic address: · Pubmed 27289566
  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Memorial Sloan Kettering Cancer Center, New York, NY. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, San Diego, CA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 26598756
2015
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
2014
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Department of Medicine, PK/PD Core Resource, Roswell Park Cancer Institute, Buffalo, New York. · Department of Urology, Roswell Park Cancer Institute, Buffalo, New York. · Section of Hematology and Oncology, University of Chicago, Chicago, Illinois. · Janssen Research and Development, Menlo Park, California. · Pubmed 25336698
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Hospital Universitario 12 de Octubre, Madrid, Spain. · Rigshospitalet, Copenhagen, Denmark. · National Institute of Oncology, Budapest, Hungary. · McMaster University, Hamilton, ON, Canada. · ICON Cancer Care, Brisbane, QLD, Australia. · University of Montreal, Montreal, QC, Canada. · Center for Oncology, Hospital Sírio-Libanês, São Paulo, Brazil. · OncoCare Cancer Centre, Singapore. · Centro Oncologico Belenus, Cuernavaca, Mexico. · University of Pisa, Pisa, Italy. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Duke Cancer Institute, Durham, NC, USA. · Pubmed 25242048
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, Los Angeles, CA. · Pubmed 24787968
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
Miscellaneous institutions in Los Angeles
2018
  • Glenn Heller, Martin Fleisher, and Howard I. Scher, Memorial Sloan Kettering Cancer Center · Howard I. Scher, Weill Cornell Medical College, New York, NY · Robert McCormack, Janssen Research & Development, Raritan, NJ · Thian Kheoh and Arturo Molina, Janssen Research & Development, Los Angeles · Dana T. Aftab, Exelixis, South San Francisco · Mohammad Hirmand, Medivation, San Francisco, CA · Matthew R. Smith, Massachusetts General Hospital, Boston · Ana Limon, Takeda Oncology, Cambridge, MA · Robert Dreicer, University of Virginia Medical School, Charlottesville, VA · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Ronald de Wit, Erasmus Medical Center, Rotterdam, the Netherlands · Karim Fizazi, Institut Gustave Roussy, Villejuif, and University of Paris Sud, Orsay, France · and Johann S. de Bono, The Institute of Cancer Research, and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 29272162
  • Glenn Heller, Memorial Sloan Kettering Cancer Center, New York, NY · Robert McCormack and Thian Kheoh, Janssen Research & Development, Raritan, NJ · Arturo Molina, Janssen Research & Development, Los Angeles, CA · Matthew R. Smith, Massachusetts General Hospital, Boston, MA · Robert Dreicer, University of Virginia Medical School, Charlottesville, VA · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Ronald de Wit, Erasmus Medical Center, Rotterdam, Netherlands · Dana T. Aftab, Exelixis, South San Francisco, CA · Mohammed Hirmand, Medivation, San Francisco, CA · Ana Limon-Carrera, Takeda Oncology, Cambridge, MA · Karim Fizazi, Institut Gustave Roussy, Villejuif, and University of Paris Sud, Orsay, France · Martin Fleisher, Memorial Sloan Kettering Cancer Center, New York, NY · Johann S. de Bono, The Institute of Cancer Research, and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom · and Howard I. Scher, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY. · Pubmed 29894273
2015
  • Department of Genitourinary Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Electronic address: · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Urology, University Hospitals of KU Leuven, Leuven, Belgium. · Department of Biostatistics Oncology, Janssen Research & Development, Raritan, New Jersey. · Department of Biostatistics and Programming, Janssen Research & Development, San Diego, California. · Department of WC Clinical Oncology, Janssen Research & Development, Los Angeles, California. · Department of Oncology, Janssen Research & Development, Los Angeles, California. · Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California. · Pubmed 26151676
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles · Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA · Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom · Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia · Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Celestia S. Higano, University of Washington, Seattle, WA · Jinhui Li, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School · Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center · Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA · Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington · Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System · Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA · Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX · Martin G. Sanda, Emory University School of Medicine, Atlanta, GA · Massimo Loda, King's College London, London, United Kingdom · Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA · and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
Unspecified
2015
  • Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center · Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College · Xiaoyu Jia, Columbia University, New York, NY · Arturo Molina, Janssen Research & Development, Menlo Park · Weimin Peng, Janssen Research & Development, Los Angeles · Thian Kheoh, Janssen Research & Development, San Diego, CA · Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research · Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom · Robert McCormack, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25800753
UCLA
2011
  • OrthoBiotech Oncology Research and Development, A Unit of Cougar Biotechnology and Institute of Urologic Oncology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California 90024, USA. · Pubmed 21239012
10 Other Locations Show
Yearly article counts 01213766443
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.